Sumitomo Pharma Co., Ltd.

Osaka, Osaka, Japan

Overview

Sumitomo Pharma Co., Ltd. is a global pharmaceutical company dedicated to developing innovative medical solutions to address unmet clinical needs. The company focuses on research and development in key therapeutic areas to enhance patient care and quality of life.

Therapeutic areas

Central Nervous SystemOncologyCardiovascularDiabetesInflammation

API / Drug Master Files

Sumitomo Pharma Co., Ltd. holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • ZONISAMIDE DRUG SUBSTANCEActive1996-11-01

FDA compliance signals

3 FDA enforcement records linked to this company.

  • 4832025-08-07

    Procedures for non-sterile drug products

  • 4832025-08-07

    Representative Samples Criteria

  • 4832025-08-07

    Backup file not maintained

Related companies

Duopharma Biotech Berhad
Malaysia
Galenicum Health Ltd.
United Kingdom
Hansoh Pharmaceutical Group Company Limited
China
Ind-Swift Laboratories Limited
India
Marion Merrell Dow Inc.
France
Sanofi Medley Farmacêutica Ltda
Brazil
Dainippon Sumitomo Pharma
Japan
Mitsubishi Tanabe Pharma Corporation
Japan

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo